283 results match your criteria: "Virchow Hospital[Affiliation]"
Eur J Dermatol
October 2018
Shanxi Key Laboratory of Stem Cell for Immunological Dermatosis, Institute of Dermatology, Taiyuan City Centre Hospital, No. 1 Dong San Dao Xiang, Jiefang Road, Taiyuan 030009, Shanxi Province, China.
Pediatr Nephrol
June 2018
Department of Paediatrics I, University Children's Hospital, Heidelberg, Germany.
Background: Infants with a body weight of less than 10 kg are often not considered to be suitable candidates for renal transplantation (RTx). The objective of this study was to evaluate this arbitrary weight threshold for pediatric RTx.
Methods: We conducted a multicenter, retrospective, match-controlled cohort study on infants weighing less than 10 kg at time of engrafting (low-weight group [LWG], n = 38) compared to a matched control group (n = 76) with a body weight of 10-15 kg, using data from the first 2 years post-transplant derived from the CERTAIN Registry.
Scand J Gastroenterol
April 2018
r Clinique Universitaire d'Hépato-Gastroentérologie, CHU Grenoble , Grenoble , France.
Objectives: Current options for patients with steroid-dependent, chronic-active ulcerative colitis (UC) with insufficient response/intolerance to immunosuppressants (ISs) and/or biologics are limited. The aim of this study was to assess the long-term outcome of granulocyte/monocyte adsorptive (GMA) apheresis (Adacolumn) in this population.
Materials And Methods: Ninety five adults with steroid-dependent active UC and insufficient response/intolerance to IS and/or TNF inhibitors received 5-8 aphereses in a single induction series of ≤10 weeks.
Dtsch Arztebl Int
July 2017
Department of Internal Medicine V: Hematology, Oncology, Rheumatology, Heidelberg University Hospital; Department of Radiotherapy and Radiooncology, Vivantes Hospital Neukölln, Berlin; Medical Center Charité Vivantes Radiotherapy, Berlin; Department of Internal Medicine I, Westpfalz Hospital Kaiserslautern; Department of Medicine: Hematology, Oncology, and Tumor Immunology, Charité Campus Virchow Hospital, Berlin; Department of Internal Medicine IV: Hematology and Oncology, University of Halle-Wittenberg, Halle (Saale).
Background: For the treatment of patients with cancer to be successful and well-tolerated, the complications and side effects of the disease and its treatment must be treated and limited as far as possible. Summarized recommendations based on the constantly increasing evidence in the area of supportive care must be defined, standardized, and communicated.
Methods: We systematically reviewed the literature on the topics of anemia, neutropenia, nausea/vomiting, diarrhea, oral mucositis, skin toxicity, and peripheral neurotoxicity induced by cancer treatment, as well as osseous complications, extravasation, and side effects of radiotherapy.
BMC Neurosci
January 2017
Division of Gastroenterology and Hepatology, Department of Medicine, Charité - Universitaetsmedizin Berlin, Campus Virchow Hospital, Augustenburger Platz 1, 13353, Berlin, Germany.
Background: There is a large body of experimental evidence suggesting that omega-3 (n-3) polyunsaturated fatty acids (PUFAs) are capable of modulating immune function. Some studies have shown that these PUFAs might have a beneficial effect in patients suffering form multiple sclerosis (MS), a chronic inflammatory demyelinating disease of the central nervous system (CNS). This could be due to increased n-3 PUFA-derived anti-inflammatory lipid mediators.
View Article and Find Full Text PDFGut
January 2018
Department of Ophthalmology, Charité University Medicine-Campus Virchow Hospital, Berlin, Germany.
Transplant Direct
July 2015
Department of Transplant Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Unlabelled: Extremely few reports have been published on experience with multiple combined pancreas-kidney re-transplantation including long-term results. We here analyze our experience with two patients following successful combined pancreas fourth-kidney third and pancreas third-kidney second transplantation.
Methods: Patient and graft survival as well as graft function and major complications were recorded.
Invest Ophthalmol Vis Sci
May 2016
Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Campus Virchow-Hospital, Berlin, Germany.
Purpose: The heat-sensitive transient receptor potential vanilloid type-1 (TRPV1) channel (i.e., capsaicin [CAP] receptor) is upregulated in numerous cancers.
View Article and Find Full Text PDFJ Crohns Colitis
July 2016
Clinique Universitaire d'Hépato-Gastroentérologie, CHU Grenoble, Grenoble, France.
Background And Aims: Patients with active, steroid-dependent ulcerative colitis with insufficient response or intolerance to immunosuppressants and/or biologic therapies have limited treatment options. Adacolumn, a granulocyte/monocyte adsorptive apheresis device, has shown clinical benefit in these patients. This study aimed to provide additional clinical data regarding the safety and efficacy of Adacolumn in this patient subgroup.
View Article and Find Full Text PDFEur J Pharmacol
August 2016
Medical Department, Division of Hepatology and Gastroenterology (including Metabolic Diseases), Charité University Medicine, Campus Virchow Hospital, Berlin, Germany; Lipid Clinic, Experimental and Clinical Research Centre (ECRC), Charité University Medicine and Max Delbrueck Center for Molecular Medicine, Berlin, Germany. Electronic address:
Recent years have seen the description and elucidation of a new class of anti-inflammatory and pro-resolving lipid mediators. The arachidonic acid (AA)-derived compounds in this class are called lipoxins and have been described in great detail since their discovery thirty years ago. The new players are mediators derived from fish oil omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), called resolvins, protectins and maresins.
View Article and Find Full Text PDFInvest New Drugs
December 2015
Department of Medical Oncology, Beaujon University Hospital, Clichy, France.
Background: This Phase-I-study aimed to determine the recommended Phase-II-dosing-schedule of LY2334737, an oral gemcitabine prodrug, in patients with advanced/metastatic solid tumors. Pharmacokinetics, cytokeratin-18 (CK18) levels, genetic polymorphisms, and antitumor activity were additionally evaluated.
Methods: Patients received escalating doses of LY2334737 either every other day for 21 days (d) followed by 7 days-drug-free period (QoD-arm) or once daily for 7 days every other week (QD-arm).
Biomed Res Int
June 2016
Institute of General Pathology, Catholic University School of Medicine, 00168 Rome, Italy ; Research Center for Biotechnology Applied to Cosmetology, Catholic University School of Medicine, 00168 Rome, Italy.
Biomed Res Int
May 2016
Institute of General Pathology, Catholic University School of Medicine, 00168 Rome, Italy ; Research Center for Biotechnology Applied to Cosmetology, Catholic University School of Medicine, 00168 Rome, Italy.
Almost forty years ago, it was first hypothesized that an increased dietary intake of omega-3 polyunsaturated fatty acids (PUFA) from fish fat could exert protective effects against several pathologies. Decades of intense preclinical investigation have supported this hypothesis in a variety of model systems. Several clinical cardiovascular studies demonstrated the beneficial health effects of omega-3 PUFA, leading medical institutions worldwide to publish recommendations for their increased intake.
View Article and Find Full Text PDFRadiology
June 2015
From the Division of Gastroenterology and Hepatology, Department of Medicine (D.C.B., H.P.M., D.M., A.F.), Department of Biostatistics and Clinical Epidemiology (U.G.), Department of General, Visceral, and Transplant Surgery (O.G., A.P.), Department of Experimental Radiology (I.S.), and Institute of Pathology (B.R.), Charité Medical School, Virchow Hospital, Humboldt-University of Berlin, Augustenburger Platz 1, 13353 Berlin, Germany; and Institute of Pathology, Klinikum Bayreuth, Germany (M.V.).
Purpose: To assess whether ultrasonography (US)-based real-time elastography (RTE) can be used to detect gut fibrosis.
Materials And Methods: In this institutional review board-approved, prospective, proof-of-concept study, unaffected and affected gut segments in 10 patients with Crohn disease (four women, six men; median age, 49 years) were examined pre-, intra-, and postoperatively with US, including RTE to assess strain. Disease activity was scored by using the Limberg index on the basis of (a) bowel wall thickness and (b) size and extent of Doppler signal.
Comput Biol Med
July 2014
Charité - Universitätsmedizin Berlin, Department of Nephrology, Campus Virchow-Hospital, Germany. Electronic address:
There exists a major concern regarding toxic effects of immunosuppressive medication on the kidney graft during post-transplant care, with observed variation in individual susceptibility to adverse drug effects amongst patients. To date, there has been no possibility to identify susceptible patients prospectively. This study analyzes medical data which includes time series of measures of renal function and trough levels of immunosuppressive drug Tacrolimus, with the main aim of identifying patients susceptible to drug toxicity.
View Article and Find Full Text PDFBiomed Res Int
April 2014
Department of Gastroenterology, Hepatology and Endocrinology, Virchow-Hospital, Charité Medical School, Free and Humboldt-University of Berlin, 13353 Berlin, Germany ; Laboratory for Lipid Medicine and Technology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
The role of non-steroidal anti-inflammatory drugs in inflammatory bowel disease is controversial, as they have been implicated in disease aggravation. Different from other cyclooxygenase inhibitors, acetylsalicylic acid (ASA) enhances the formation of anti-inflammatory and proresolution lipoxins derived from arachidonic acid as well as resolvins from omega-3 polyunsaturated fatty acids such as docosahexaenoic acid (DHA). In this study, we examined the effect of ASA on murine dextran sodium sulfate colitis.
View Article and Find Full Text PDFAnticancer Res
April 2013
Department of Gynecological Oncology, [corrected] Campus Virchow Hospital, Berlin, Germany.
A case report of lethal distant myonecrosis with gas gangrene is presented. Blood cultures and tissue biopsies revealed Clostridium septicum. The 55-year-old female patient presented with recurrent ovarian cancer of transitional cell type, initially diagnosed as FIGO IIb in January 2011, with hepatic metastasis and invasion of the ceacal wall.
View Article and Find Full Text PDFLancet
November 2012
Department of Medicine, Division of Gastroenterology and Hepatology, Charité Medical Centre, Virchow Hospital, Medical School of the Humboldt-University of Berlin, Berlin, Germany.
Crohn's disease is a relapsing systemic inflammatory disease, mainly affecting the gastrointestinal tract with extraintestinal manifestations and associated immune disorders. Genome wide association studies identified susceptibility loci that--triggered by environmental factors--result in a disturbed innate (ie, disturbed intestinal barrier, Paneth cell dysfunction, endoplasmic reticulum stress, defective unfolded protein response and autophagy, impaired recognition of microbes by pattern recognition receptors, such as nucleotide binding domain and Toll like receptors on dendritic cells and macrophages) and adaptive (ie, imbalance of effector and regulatory T cells and cytokines, migration and retention of leukocytes) immune response towards a diminished diversity of commensal microbiota. We discuss the epidemiology, immunobiology, amd natural history of Crohn's disease; describe new treatment goals and risk stratification of patients; and provide an evidence based rational approach to diagnosis (ie, work-up algorithm, new imaging methods [ie, enhanced endoscopy, ultrasound, MRI and CT] and biomarkers), management, evolving therapeutic targets (ie, integrins, chemokine receptors, cell-based and stem-cell-based therapies), prevention, and surveillance.
View Article and Find Full Text PDFJ Hum Lact
November 2012
Charité Virchow Hospital, University Medicine Berlin, Berlin, Germany.
Background: Vascular endothelial growth factor (VEGF) and its receptors regulate angiogenesis (formation of blood vessels). The soluble VEGF receptor 1 (sFlt-1) binds VEGF as a potent antagonist.
Objective: The objective of this study was to compare VEGF and sFlt-1 levels in milk from mothers of preterm (n = 50) versus term (n = 49) infants in a longitudinal study.
Geburtshilfe Frauenheilkd
May 2012
Department of Obstetric Medicine, Charité - University Medicine Berlin, Virchow Hospital Campus, Berlin.
There are no current health care studies from Germany regarding the "morning-after pill". This paper will use routine data to analyse details regarding the users' profiles, reasons for using it and the utilisation of hospital outpatient facilities. Retrospective analysis of all triage sheets in the emergency department of the Virchow Hospital Campus/Charité University Hospital, Berlin, over a four-year period from 2007 to 2010 that were coded with the ICD diagnosis Z30 (= contraception advice) and statistical processing of the associated administrative data.
View Article and Find Full Text PDFEur J Pediatr
September 2012
Department of Pediatric Pneumology and Immunology, Campus Virchow Hospital, Charité Medical University, Augustenburger Platz 1, 13353 Berlin, Germany.
Hereditary angioedema due to C1 inhibitor (C1 esterase inhibitor) deficiency (types I and II HAE-C1-INH) is a rare disease that usually presents during childhood or adolescence with intermittent episodes of potentially life-threatening angioedema. Diagnosis as early as possible is important to avoid ineffective therapies and to properly treat swelling attacks. At a consensus meeting in June 2011, pediatricians and dermatologists from Germany, Austria, and Switzerland reviewed the currently available literature, including published international consensus recommendations for HAE therapy across all age groups.
View Article and Find Full Text PDFGut
February 2013
Central Interdisciplinary Endoscopy, Charité Medical University, Campus Virchow Hospital, Berlin, Germany.
Background: Screening colonoscopy (SC) outcome quality is best determined by the adenoma detection rate (ADR). The substantial variability in the ADRs between endoscopists may reflect different skills, experience and/or equipment.
Objective: To analyse the potential factors that may influence ADR variance, including case volume.
Prostaglandins Other Lipid Mediat
March 2012
Department of Gastroenterology, Hepatology and Endocrinology, Charité University Medicine, Rudolf-Virchow-Hospital, Berlin, Germany.
Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have long been associated with decreased inflammation and are also implicated in the prevention of tumorigenesis. Conventional thinking attributed this mainly to a suppressive effect of these fatty acids on the formation of arachidonic acid-derived prostaglandins and leukotrienes. Recent years have seen the discovery of a new class of inflammation-dampening and resolution-promoting n-3 PUFA-derived lipid mediators called resolvins and protectins.
View Article and Find Full Text PDFInflammopharmacology
February 2012
Division of Gastroenterology and Hepatology, Department of Medicine, Charité Medical Center, Virchow Hospital, Medical School of the Humboldt University of Berlin, Berlin, Germany.
Crohn's disease and ulcerative colitis are two chronic inflammatory bowel diseases. Current biologic therapies are limited to blocking tumor necrosis factor alpha. However, some patients are primary non-responders, experience a loss of response, intolerance or side effects defining the urgent unmet need for novel treatments.
View Article and Find Full Text PDFDig Dis
March 2012
Division of Gastroenterology and Hepatology, Department of Medicine, Charité Medical Center - Virchow Hospital, Medical School of Humboldt University of Berlin, Berlin, Germany.
Crohn's disease and ulcerative colitis are chronic inflammatory diseases resulting from an inappropriate innate and adaptive immune response towards commensal microbiota. Patients with Crohn's disease and ulcerative colitis carry an increased risk of developing colon cancer and/or small bowel carcinoma, respectively. The colorectal cancer risks of ulcerative colitis and Crohn's disease with comparable surface area involvement and disease duration are very similar.
View Article and Find Full Text PDF